Scientific American Content | Global Follow Moderna and Merck announce ‘landmark’ trial showing mRNA therapy significantly cuts odds of recurrent skin cancer The combined drug works by nudging the body’s own immune system to make proteins that attack and destroy melanoma cells https://www.scientificamerican.com/article/moderna-and-merck-announce-landmark-trial-showing-mrna-therapy-significantly-cuts-odds-of-recurrent-skin-cancer/ scientificamerican.com
